Cvrx Inc (CVRX)

$6.96 -0.16 (-2.25%)
Market Cap 179.54M
Revenue (ttm) 51.29M
Net Income (ttm) -59.97M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -116.92%
Debt to Equity Ratio 1.03
Volume 175,500
Avg Vol 269,036
Day's Range N/A - N/A
Shares Out 26.21M
Stochastic %K 56%
Beta 1.31
Analysts Strong Sell
Price Target $11.50

Company Profile

CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, a neuromodulation device that enhance symptoms for patients with heart failure by delivering electrical pulses to baroreceptors. It sells its products through direct sales force, sales agents, and independent distributors. The company was...

Industry: Medical Devices
Sector: Healthcare
Phone: 763 416 2840
Fax: 763 416 2841
Address:
9201 West Broadway Avenue, Suite 650, Minneapolis, United States
Twister8
Twister8 Jan. 30 at 3:51 PM
$CVRX bailed at 7.60, will reload sub 5
1 · Reply
MedDevice
MedDevice Jan. 29 at 8:44 PM
$CVRX market appropriately pricing the impact of the trial. Will be important for analysts to determine future y/o/y and q/o/q growth based on trial volume increases to understand where commercial incremental growth is occurring for approved indication.
0 · Reply
MITornado
MITornado Jan. 29 at 5:48 PM
$CVRX blood in the streets
0 · Reply
Twister8
Twister8 Jan. 26 at 3:23 PM
$CVRX the meddevice guy blocked me cuz I asked him if he owns any... he is a hack, fished him out.
1 · Reply
intrader
intrader Jan. 23 at 5:06 PM
$CVRX I'm out. It may go higher.
0 · Reply
newfguy
newfguy Jan. 23 at 4:47 PM
$CVRX nice pop, good move to fade
1 · Reply
Stackdoe1
Stackdoe1 Jan. 23 at 4:13 PM
$CVRX $25
0 · Reply
intrader
intrader Jan. 23 at 4:08 PM
$CVRX I'm in.
0 · Reply
Stackdoe1
Stackdoe1 Jan. 23 at 3:11 PM
$AUST $NAMM $CVRX
0 · Reply
MITornado
MITornado Jan. 23 at 2:45 PM
$CVRX 200k shares in ten minutes. Used to take 4 full days to get that type of volume.
0 · Reply
Latest News on CVRX
CVRx to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call on February 12, 2026

Jan 29, 2026, 4:10 PM EST - 5 days ago

CVRx to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call on February 12, 2026

CVRx Kicks Off One Of The Largest Heart Device Trials In History

Jan 23, 2026, 12:33 PM EST - 11 days ago

CVRx Kicks Off One Of The Largest Heart Device Trials In History

CVRx Announces Initiation of BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population

Jan 22, 2026, 4:05 PM EST - 12 days ago

CVRx Announces Initiation of BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population

CVRx, Inc. (CVRX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 14, 2026, 9:15 PM EST - 20 days ago

CVRx, Inc. (CVRX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2025 Financial Results and Issues Fiscal 2026 Guidance

Jan 12, 2026, 8:00 AM EST - 23 days ago

CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2025 Financial Results and Issues Fiscal 2026 Guidance

CVRx Announces Implementation of New Category I CPT Codes for Barostim Therapy

Jan 6, 2026, 8:30 AM EST - 4 weeks ago

CVRx Announces Implementation of New Category I CPT Codes for Barostim Therapy

CVRx to Present at the 44th Annual J.P. Morgan Healthcare Conference

Dec 22, 2025, 8:30 AM EST - 6 weeks ago

CVRx to Present at the 44th Annual J.P. Morgan Healthcare Conference

CVRx to Participate at the Piper Sandler 37th Annual Healthcare Conference

Nov 19, 2025, 8:30 AM EST - 2 months ago

CVRx to Participate at the Piper Sandler 37th Annual Healthcare Conference

CVRx, Inc. (CVRX) Q3 2025 Earnings Call Transcript

Nov 5, 2025, 10:51 PM EST - 3 months ago

CVRx, Inc. (CVRX) Q3 2025 Earnings Call Transcript

CVRx to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call on Nov. 5, 2025

Oct 22, 2025, 4:30 PM EDT - 3 months ago

CVRx to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call on Nov. 5, 2025

CVRx, Inc. (CVRX) Q2 2025 Earnings Call Transcript

Aug 4, 2025, 7:27 PM EDT - 6 months ago

CVRx, Inc. (CVRX) Q2 2025 Earnings Call Transcript

CVRx Reports Second Quarter 2025 Financial and Operating Results

Aug 4, 2025, 4:05 PM EDT - 6 months ago

CVRx Reports Second Quarter 2025 Financial and Operating Results

CVRx to Present at the Canaccord Genuity 45th Annual Growth Conference

Jul 29, 2025, 8:30 AM EDT - 6 months ago

CVRx to Present at the Canaccord Genuity 45th Annual Growth Conference

CVRx Announces Positive News on Outpatient Payment for Barostim

Jul 16, 2025, 7:30 AM EDT - 7 months ago

CVRx Announces Positive News on Outpatient Payment for Barostim

CVRx: Sell-Off Ignores Its True Potential

Jul 2, 2025, 4:02 AM EDT - 7 months ago

CVRx: Sell-Off Ignores Its True Potential

CVRx to Present at the William Blair 45th Annual Growth Stock Conference

May 28, 2025, 4:30 PM EDT - 8 months ago

CVRx to Present at the William Blair 45th Annual Growth Stock Conference

CVRx, Inc. (CVRX) Q1 2025 Earnings Conference Call Transcript

May 10, 2025, 3:51 PM EDT - 9 months ago

CVRx, Inc. (CVRX) Q1 2025 Earnings Conference Call Transcript

CVRx to Report First Quarter 2025 Financial and Operating Results and Host Conference Call on May 8, 2025

Apr 24, 2025, 4:30 PM EDT - 10 months ago

CVRx to Report First Quarter 2025 Financial and Operating Results and Host Conference Call on May 8, 2025

CVRx Inc: Overreaction Creates Buying Opportunity

Apr 9, 2025, 8:45 AM EDT - 10 months ago

CVRx Inc: Overreaction Creates Buying Opportunity

Greenbrier, RPM International, CVRx And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Apr 8, 2025, 8:35 AM EDT - 10 months ago

Greenbrier, RPM International, CVRx And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

GBX RPM

CVRx Reports Preliminary First Quarter 2025 Financial Results

Apr 7, 2025, 4:05 PM EDT - 10 months ago

CVRx Reports Preliminary First Quarter 2025 Financial Results

CVRx announces new real-world evidence demonstrating significant reductions in healthcare utilization with Barostim

Feb 12, 2025, 2:45 PM EST - 1 year ago

CVRx announces new real-world evidence demonstrating significant reductions in healthcare utilization with Barostim

CVRx, Inc. (CVRX) Q4 2024 Earnings Conference Call Transcript

Feb 4, 2025, 11:00 PM EST - 1 year ago

CVRx, Inc. (CVRX) Q4 2024 Earnings Conference Call Transcript

CVRx Reports Fourth Quarter and Full Year 2024 Financial and Operating Results

Feb 4, 2025, 4:05 PM EST - 1 year ago

CVRx Reports Fourth Quarter and Full Year 2024 Financial and Operating Results

CVRx to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call on February 4, 2025

Jan 21, 2025, 4:30 PM EST - 1 year ago

CVRx to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call on February 4, 2025

CVRx to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Dec 23, 2024, 4:30 PM EST - 1 year ago

CVRx to Present at the 43rd Annual J.P. Morgan Healthcare Conference

CVRx to Present at the Piper Sandler 36th Annual Healthcare Conference

Nov 20, 2024, 4:30 PM EST - 1 year ago

CVRx to Present at the Piper Sandler 36th Annual Healthcare Conference

CVRx: Impressive Top-Line Growth Seems Priced In

Nov 6, 2024, 9:04 PM EST - 1 year ago

CVRx: Impressive Top-Line Growth Seems Priced In

CVRx, Inc. (CVRX) Q3 2024 Earnings Call Transcript

Oct 29, 2024, 10:38 PM EDT - 1 year ago

CVRx, Inc. (CVRX) Q3 2024 Earnings Call Transcript

CVRx announces new CPT® Category I codes for Barostim

Oct 18, 2024, 2:08 PM EDT - 1 year ago

CVRx announces new CPT® Category I codes for Barostim

CVRx to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call on October 29, 2024

Oct 15, 2024, 4:30 PM EDT - 1 year ago

CVRx to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call on October 29, 2024

CVRx Announces Appointment of Two New Board Members

Sep 3, 2024, 8:30 AM EDT - 1 year ago

CVRx Announces Appointment of Two New Board Members

CVRx, Inc. (CVRX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

Aug 19, 2024, 4:00 PM EDT - 1 year ago

CVRx, Inc. (CVRX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

The Schall Law Firm Is Investigating CVRx Inc For Securities Fraud And Urging Investors To Join

Aug 19, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Is Investigating CVRx Inc For Securities Fraud And Urging Investors To Join

The Schall Law Firm Is Seeking CVRx Inc Shareholders To Join Fraud Investigation

Aug 18, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Is Seeking CVRx Inc Shareholders To Join Fraud Investigation

CVRx Inc Shareholders Can Join Fraud Investigation With The Schall Law Firm

Aug 17, 2024, 11:00 AM EDT - 1 year ago

CVRx Inc Shareholders Can Join Fraud Investigation With The Schall Law Firm

CVRx Inc Investors Encouraged To Participate In Fraud Inquiry With The Schall Law Firm

Aug 16, 2024, 11:00 AM EDT - 1 year ago

CVRx Inc Investors Encouraged To Participate In Fraud Inquiry With The Schall Law Firm

CVRx Inc Shareholders Urged To Participate In Fraud Inquiry With The Schall Law Firm

Aug 15, 2024, 11:00 AM EDT - 1 year ago

CVRx Inc Shareholders Urged To Participate In Fraud Inquiry With The Schall Law Firm

CVRx Inc Shareholders Invited To Join Fraud Inquiry With The Schall Law Firm

Aug 14, 2024, 10:30 PM EDT - 1 year ago

CVRx Inc Shareholders Invited To Join Fraud Inquiry With The Schall Law Firm

Twister8
Twister8 Jan. 30 at 3:51 PM
$CVRX bailed at 7.60, will reload sub 5
1 · Reply
MedDevice
MedDevice Jan. 29 at 8:44 PM
$CVRX market appropriately pricing the impact of the trial. Will be important for analysts to determine future y/o/y and q/o/q growth based on trial volume increases to understand where commercial incremental growth is occurring for approved indication.
0 · Reply
MITornado
MITornado Jan. 29 at 5:48 PM
$CVRX blood in the streets
0 · Reply
Twister8
Twister8 Jan. 26 at 3:23 PM
$CVRX the meddevice guy blocked me cuz I asked him if he owns any... he is a hack, fished him out.
1 · Reply
intrader
intrader Jan. 23 at 5:06 PM
$CVRX I'm out. It may go higher.
0 · Reply
newfguy
newfguy Jan. 23 at 4:47 PM
$CVRX nice pop, good move to fade
1 · Reply
Stackdoe1
Stackdoe1 Jan. 23 at 4:13 PM
$CVRX $25
0 · Reply
intrader
intrader Jan. 23 at 4:08 PM
$CVRX I'm in.
0 · Reply
Stackdoe1
Stackdoe1 Jan. 23 at 3:11 PM
$AUST $NAMM $CVRX
0 · Reply
MITornado
MITornado Jan. 23 at 2:45 PM
$CVRX 200k shares in ten minutes. Used to take 4 full days to get that type of volume.
0 · Reply
OpenOutcrier
OpenOutcrier Jan. 23 at 1:29 PM
$CVRX (+3.8% pre) CVRX begins heart failure trial for expanded patient population https://ooc.bz/l/90543
0 · Reply
MITornado
MITornado Jan. 22 at 11:20 PM
$CVRX so Medicare pays for these patients devices who are enrolled in the trial correct? Guaranteed patient volume increase… no?
1 · Reply
MedDevice
MedDevice Jan. 22 at 9:54 PM
$CVRX https://ir.cvrx.com/news-releases/news-release-details/cvrx-announces-initiation-benefit-hf-landmark-heart-failure
1 · Reply
MedDevice
MedDevice Jan. 21 at 6:03 PM
$CVRX https://www.medtechdive.com/news/jnj-q4-full-year-earnings-cardiovascular/810121/ JNJ is the largest shareholder of CVRx, hyper focused on cardiology and still hasn’t made a decision to pull in CVRx to manage this technology. Why?
2 · Reply
MedDevice
MedDevice Jan. 21 at 3:21 PM
$CVRX insider buying?
1 · Reply
MITornado
MITornado Jan. 20 at 10:51 AM
$CVRX macro dump is looking nasty
1 · Reply
BillionerOfKing
BillionerOfKing Jan. 19 at 5:14 PM
$CVRX Current Stock Price: $5.21 Contracts to trade: $12.5 CVRX Feb 20 2026 Call Entry: $0.21 Exit: $0.39 ROI: 87% Hold ~25 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
SuperGreenToday
SuperGreenToday Jan. 19 at 1:47 PM
$CVRX Share Price: $5.21 Contract Selected: Dec 18, 2026 $5 Calls Buy Zone: $2.91 – $3.59 Target Zone: $4.99 – $6.10 Potential Upside: 62% ROI Time to Expiration: 332 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
davidbo
davidbo Jan. 16 at 8:55 PM
$CVRX since 2021 cvrx has lost 80% of its valuation, continued sales with out the discipline to be profitable is a cancer for any company. I do however, have to say that you boys are good at lying and selling stock .also not bad at paying high interest rates to keep your personal gravy train running.
0 · Reply
Twister8
Twister8 Jan. 16 at 6:22 PM
$CVRX mgmt has set themselves up for no disappointment, not even one downward revenue estimate… good luck… spec only
0 · Reply
MITornado
MITornado Jan. 16 at 2:41 PM
$CVRX assuming the guys never got over 50 million a year, a 140 million valuation would be paid back by an aquirer within three years. Low risk to buy here.
3 · Reply
MedDevice
MedDevice Jan. 16 at 1:33 AM
$CVRX The time spent in the JPM presentation on the referral pattern provided great insight to how complex it is to get a patient implanted with this therapy and how many call points are required. Kudos to leadership for explaining how tough this is to scale. Is this an advanced HF therapy? Is this a generally accepted therapy for cardiology?
0 · Reply